Explore our bio-active plant derivatives researched for supporting lipid profiles and combating low HDL/high LDL imbalances.
A High-Tech Pioneer in Plant Science & Natural Pharmaceutical APIs
Chengdu ChenLv Herb Co.,Ltd. was established in 2012 as a modern high-tech enterprise specializing in the research, development, extraction, purification, and commercialization of premium botanical active ingredients. We serve globally recognized companies across the pharmaceutical, nutraceutical, veterinary health, and functional cosmetic sectors.
Our core mission focuses on supplying high-purity natural compounds designed to support public health. In the context of global metabolic and cardiovascular disease management, we supply verified ingredients that assist in mitigating high LDL cholesterol, promoting reverse cholesterol transport, and optimizing metabolic homeostasis.
A decade of research innovation in natural compounds extraction.
How Plant-Derived Phytochemicals Modulate Cholesterol Transport and Reduce Cardiovascular Risks.
Dyslipidemia characterized by Low High-Density Lipoprotein (HDL) and High Low-Density Lipoprotein (LDL) represents a primary driver of atherosclerotic cardiovascular disease (ASCVD). While synthetic statins serve as the standard pharmacological intervention, global researchers and functional food formulators are actively investigating natural botanical compounds to offer synergistic support, improve tolerance profiles, and provide comprehensive lipid-clearing support.
Low HDL limits the efficiency of Reverse Cholesterol Transport (RCT), the mechanism by which peripheral cholesterol is shuttled back to the liver for excretion. Concurrently, elevated circulating LDL molecules—especially when converted into oxidized LDL (oxLDL)—infiltrate the arterial intima, giving rise to foam cells and arterial plaque accumulation. Maintaining healthy lipid ratios requires a multi-target botanical strategy:
Scientific validation has illuminated specific botanical actives that support healthy lipid management:
Gynostemma extract, rich in gypenosides, stimulates AMP-activated protein kinase (AMPK). This pathway acts as a metabolic master switch, downregulating fatty acid synthesis and inhibiting HMG-CoA reductase activity naturally.
Hesperidin and Diosmin reduce capillary permeability, support vascular elasticity, and inhibit the secretion of Apolipoprotein B (ApoB), effectively lowering the production of LDL precursors in hepatocytes.
TUDCA (Tauroursodeoxycholic Acid) and Sodium Deoxycholate support lipid emulsification, reduce endoplasmic reticulum stress in metabolic organs, and encourage bile flow, which plays a major role in cholesterol excretion pathways.
Why Chengdu Chenlv Herb is the Partner of Choice for Global Enterprises
Sichuan is a world-renowned ecological treasury of herbal medicines. Our close proximity to wild harvesting regions and sustainable cultivation bases allows us to secure highly potent raw botanicals at optimized cost points.
Equipped with multi-stage countercurrent extraction systems, column chromatography, membrane separation, and clean-room spray drying, our facility ensures maximum active substance yields, clean solubility, and strict batch-to-batch consistency.
We implement strict quality assurance protocols matching ISO9001 and ISO22000 standards. Raw materials undergo rigorous heavy metal, residual solvent, and pesticide analysis to meet EU and FDA import standards.
Navigating global regulations to ensure safe, compliant, and continuous supply chains
Supplying health ingredients requires navigate complex global systems. In the United States, ingredients must meet DSHEA (Dietary Supplement Health and Education Act) requirements, and facilities must be registered under the FDA. In Europe, EFSA guidelines dictate strict health claim validation and Novel Food status verification.
At Chengdu Chenlv Herb, we assist our partners by providing complete technical documentation packages, including COAs (Certificates of Analysis), allergen statements, non-GMO declarations, and BSE/TSE-free certification, ensuring swift customs clearance and regulatory approval in destination countries.
Flexible purchasing agreements, tailor-made contract manufacturing, and strict quality control for B2B buyers
We cater to high-volume procurement schedules with reliable batch stability. Standard package ranges from 25kg drums to metric-ton volumes for industrial-scale encapsulation and liquid filling operations.
Need specific active concentrations? We customize extract ratios and dry powder properties (mesh size, bulk density, flowability) to match your direct tableting or softgel production parameters.
Leverage our in-house lab formulation capabilities to develop synergistic herbal combinations targeting lipid regulation, weight management, and healthy circulatory functions.
Chenlv Herb provides comprehensive, step-by-step contract manufacturing services
Communicate and determine product specifications
Receive detailed proposal and pricing options
Establish legal and operational parameters
R&D lab-scale sample formulation and testing
Mass manufacture scheduling post-sample sign-off
Rigorous lab analysis and Certificate release
Secure packing and global logistics coordination
Translating natural compounds into consumer-ready formulas
Driven by the concept of "homology of medicine and food" and modern wellness trends, botanical extracts have become primary raw ingredients in dietary supplements for metabolic health, assisting in long-term blood lipid management.
Plant extracts play a vital role in pharmaceuticals due to their stable active structures. We supply high-purity APIs (like Diosmin and TUDCA) designed for cardiovascular, hepatic, and microcirculatory drug manufacturing.
With growing consumer demand for clean-label skincare, botanical extracts offer natural, skin-compatible solutions. Standardized actives supply skin-barrier support, soothing properties, and combat photo-aging.
Natural additives enhance livestock immunity and growth efficiency. Plant actives are widely studied for optimising liver lipid processing and reducing synthetic chemical usage in veterinary feeds.
Our commitment to safety and quality is backed by international verification standards
How evolving market demands are reshaping active ingredient sourcing
The global market for metabolic health formulations is shifting rapidly. Consumer preferences are driving brands away from isolated synthetic compounds and toward standardized plant-based matrices. This trend is driven by three main factors:
Crucial procurement insights and technical answers for regulatory and QA directors
High-purity chemical components and isolated botanical extracts designed for target metabolic formulations.
Stay updated with research findings, market price dynamics, and exhibition news
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season (May-June) comes to an end and new supplies gradually enter the market, price fluctuations have become a focal point due to supply and demand dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery.
Join our botanical chemical extraction experts at the API conference to discuss new technology solutions, custom synthesis, and quality standards for metabolic health raw materials.
